利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

47 条记录 (耗时 0.028 秒)

    3D image composition/display apparatus and composition method based on front-to-back order of plural 2D projected images
    1.
    发明授权
    3D image composition/display apparatus and composition method based on front-to-back order of plural 2D projected images 失效
    基于多个2D投影图像的前后顺序的3D图像合成/显示装置和合成方法

    公开(公告)号：US5995108A

    公开(公告)日：1999-11-30

    申请号：US665986

    申请日：1996-06-19

    申请人： Yoshiaki Isobe ,  Koichi Sano ,  Michio Oikawa

    发明人： Yoshiaki Isobe ,  Koichi Sano ,  Michio Oikawa

    IPC分类号： A61B6/03 ,  A61B5/055 ,  G06T1/00 ,  G06T15/08 ,  G09G1/06 ,  G06F3/153

    CPC分类号： G09G1/06 ,  G06T15/06 ,  G06T15/08

    摘要： An apparatus for composing and displaying a three-dimensional image comprises a device for computing a plurality of two-dimensional projected images from the same direction of a viewing line by a volume rendering scheme for each of a plurality of regions of interest set on three-dimensional data, a device for determining degrees to which each pixel of a plurality of two-dimensional projected images is involved in the display using the computed two-dimensional projected images and representative display surface depth values, each obtained for each pixel of the two-dimensional projected images, and a device for determining the total sum of the degrees of display involvement for each projection point and determining the pixel value of the projection plane.

    摘要翻译： 一种用于组合和显示三维图像的装置包括一个装置，用于通过体积绘制方案从观看线的相同方向计算多个二维投影图像，用于在三维图像上设置的多个感兴趣区域中的每一个， 尺寸数据，用于使用所计算的二维投影图像和代表性显示表面深度值来确定多个二维投影图像中的每个像素参与显示的度的装置， 以及用于确定每个投影点的显示参与程度的总和并确定投影平面的像素值的装置。

    Three-dimensional image producing method and apparatus
    2.
    发明授权
    Three-dimensional image producing method and apparatus 失效
    三维图像制作方法及装置

    公开(公告)号：US5630034A

    公开(公告)日：1997-05-13

    申请号：US415941

    申请日：1995-04-03

    申请人： Michio Oikawa ,  Koichi Sano ,  Yoshiaki Isobe

    发明人： Michio Oikawa ,  Koichi Sano ,  Yoshiaki Isobe

    IPC分类号： A61B6/03 ,  A61B5/055 ,  G06T1/00 ,  G06T15/08 ,  G06F15/00

    CPC分类号： G06T15/08

    摘要： A three-dimensional image producing method of determining, as display candidates, voxel data having a value exceeding a display threshold set for density, and voxel data of a specified classification selected from among voxel data classified into a plurality of display classifications, and projecting the voxel data as the display candidates onto a projection plane on the basis of predetermined display conditions to form a three-dimensional image.

    摘要翻译： 一种三维图像产生方法，用于确定具有超过为密度设置的显示阈值的值的体素数据作为显示候选，以及从分类为多个显示分类的体素数据中选择的指定分类的体素数据，并且将 基于预定的显示条件将体素数据作为显示候选到投影平面上，以形成三维图像。

    NOVEL ADENINE COMPOUND
    4.
    发明申请
    NOVEL ADENINE COMPOUND 失效
    新颖的化合物

    公开(公告)号：US20100099870A1

    公开(公告)日：2010-04-22

    申请号：US12531867

    申请日：2008-03-19

    申请人： Yoshiaki Isobe ,  Tomoaki Nakamura

    发明人： Yoshiaki Isobe ,  Tomoaki Nakamura

    IPC分类号： C07D473/18

    CPC分类号： C07D473/18 ,  C07D473/00

    摘要： A novel adenine compound represented by the formula (1): [wherein R1 is substituted or unsubstituted alkyl, etc., X is oxygen, etc., A1 is 4- to 8-membered substituted or unsubstituted saturated nitrogen-containing heterocycle containing 1 to 2 hetero atom(s) selected from 1 to 2 nitrogen(s), 0 to 1 oxygen and 0 to 1 sulfur, etc., A2 is substituted or unsubstituted 6- to 10-membered aryl, etc., L1 and L2 are independently a straight chain or branched chain alkylene, etc.], or a pharmaceutically acceptable salt thereof, which is useful as a medicament.

    摘要翻译： 由式（1）表示的新型腺嘌呤化合物：其中，R 1为取代或未取代的烷基等，X为氧等，A 1为4〜8元的取代或未取代的饱和含氮杂环， 2个选自1至2个氮，0至1个氧和0至1个硫等的杂原子，A2为取代或未取代的6-至10-元芳基等，L1和L2独立地为 直链或支链亚烷基等]或其药学上可接受的盐，其可用作药物。

    User identification system and a method thereof
    5.
    发明申请
    User identification system and a method thereof 有权
    用户识别系统及其方法

    公开(公告)号：US20100011423A1

    公开(公告)日：2010-01-14

    申请号：US12379639

    申请日：2009-02-26

    申请人： Yoshiaki Isobe ,  Takao Murakami ,  Kenta Takahashi

    发明人： Yoshiaki Isobe ,  Takao Murakami ,  Kenta Takahashi

    IPC分类号： H04L9/32 ,  G06F21/00

    CPC分类号： G06F21/32 ,  G06F21/31 ,  G07C9/00158

    摘要： A service providing system using the biometrics identification without inputting the user ID poses the problem that the consideration of a service is erroneously claimed to the registered user not using the service due to the erroneous identification. According to this invention, the threshold of the value of the degree of similarity for user identification is set strictly for each registered biometrics information of the user in accordance with the declaration of the loss caused by the erroneous identification.

    摘要翻译： 在不输入用户ID的情况下使用生物特征识别的服务提供系统造成了由于错误识别而使服务错误地要求给注册用户不使用服务的问题。 根据本发明，根据由错误识别引起的损失的声明，对用户的每个登记生物特征信息严格地设定用户识别度的相似度值的阈值。

    Biometric Authenticaton System and Method with Vulnerability Verification
    6.
    发明申请
    Biometric Authenticaton System and Method with Vulnerability Verification 失效
    生物特征识别系统和脆弱性验证方法

    公开(公告)号：US20090307764A1

    公开(公告)日：2009-12-10

    申请号：US12293470

    申请日：2007-03-23

    申请人： Yoshiaki Isobe ,  Masahiro Mimura

    发明人： Yoshiaki Isobe ,  Masahiro Mimura

    IPC分类号： H04L9/32 ,  G06F21/20

    CPC分类号： G06F21/32 ,  G06F21/51 ,  G06F21/577 ,  G06F2221/2101 ,  H04L9/3231

    摘要： A biometric authentication device has a threat of an attack of pretending to be someone else by such as forgery. The present invention supports a service provider to appropriately decide the level of such threat.A vulnerability verification server 150 is provided in the system, and the vulnerability of each biometric product is centrally managed. A service provider 130 sends the information that specifies the device in which a client terminal 110 executes the biometric authentication to the vulnerability verification server 150, and receives the vulnerability information. The service provider 130 decides whether the service can be provided or not to the client terminal 110 using the vulnerability information that was received.

    摘要翻译： 生物识别认证设备有伪装的假冒伪装的威胁。 本发明支持服务提供商适当地确定这种威胁的程度。 系统中提供了一个漏洞验证服务器150，并且集中管理每个生物特征产品的漏洞。 服务提供者130将指定客户终端110的设备的信息发送到漏洞验证服务器150，并接收该漏洞信息。 服务提供者130使用接收到的漏洞信息来判定是否可以向客户终端110提供服务。

    Adenine derivatives
    8.
    发明授权
    Adenine derivatives 失效
    腺嘌呤衍生物

    公开(公告)号：US07157465B2

    公开(公告)日：2007-01-02

    申请号：US10474199

    申请日：2002-04-15

    申请人： Yoshiaki Isobe ,  Haruhisa Ogita ,  Masanori Tobe ,  Haruo Takaku ,  Tetsuhiro Ogino ,  Ayumu Kurimoto ,  Hajime Kawakami

    发明人： Yoshiaki Isobe ,  Haruhisa Ogita ,  Masanori Tobe ,  Haruo Takaku ,  Tetsuhiro Ogino ,  Ayumu Kurimoto ,  Hajime Kawakami

    IPC分类号： C07D473/16 ,  C07D473/18 ,  C07D473/24 ,  A61K31/52 ,  A61K31/522

    CPC分类号： C07D473/00 ,  C07D473/16 ,  C07D473/18 ,  C07D473/24 ,  C07D473/34

    摘要： This invention relates to an adenine derivative, a tautomer thereof, or a pharmaceutically acceptable salt thereof represented by general formula (I): wherein X represents NR3 (wherein R3 represents a hydrogen atom or C1-3 alkyl) or the like; R1 represents substituted or unsubstituted alkyl or the like; R2 represents hydroxyl or the like; and Y represents a substituted or unsubstituted aromatic hetero ring or the like. Also, the present invention relates to pharmaceuticals such as an interferon inducer, antiviral agent, anticancer agent, type 2 helper T cell selective immune response inhibitor, antiallergic agent, and immune response modulator comprising the above derivative as an active ingredient.

    摘要翻译： 本发明涉及由通式（I）表示的腺嘌呤衍生物，其互变异构体或其药学上可接受的盐：其中X表示NR 3（其中R 3表示 氢原子或C 1-3烷基）等; R 1表示取代或未取代的烷基等; R 2表示羟基等; Y表示取代或未取代的芳族杂环等。 此外，本发明涉及包含上述衍生物作为活性成分的药物，例如干扰素诱导剂，抗病毒剂，抗癌剂，2型辅助T细胞选择性免疫应答抑制剂，抗过敏剂和免疫应答调节剂。

    9-substituted 8-oxoadenine compound
    10.
    发明授权
    9-substituted 8-oxoadenine compound 有权
    9-取代的8-氧代腺嘌呤化合物

    公开(公告)号：US08012964B2

    公开(公告)日：2011-09-06

    申请号：US10593691

    申请日：2005-03-24

    申请人： Ayumu Kurimoto ,  Yoshiaki Isobe ,  Stephen Brough ,  Hiroki Wada ,  Roger Bonnert ,  Thomas McInally

    发明人： Ayumu Kurimoto ,  Yoshiaki Isobe ,  Stephen Brough ,  Hiroki Wada ,  Roger Bonnert ,  Thomas McInally

    IPC分类号： C07D473/18 ,  A61K31/522 ,  A61P37/06 ,  A61P37/08 ,  A61P11/06

    CPC分类号： C07D473/18 ,  A61K31/522 ,  A61K31/5377

    摘要： The present invention provides an 8-oxoadenine compound having immunemodulating activities such as an interferon inducing activity and useful as an antiviral agent and antiallergic agent, which is represented by the following formula (1): [wherein the ring A represents a 6-10 membered aromatic carbocyclic ring and the like, R represents a halogen atom, an alkyl group and the like, n represents an integer of 0-2, Z1 represents alkylene, X2 represents oxygen atom, sulfur atom, SO2, NR5, CO, CONR5, NR5CO and the like, Y1, Y2 and Y3 represent independently a single bond or an alkylene group, X1 represents oxygen atom, sulfur atom, NR4 (R4 is hydrogen atom or an alkyl group) or a single bond, R2 represents a substituted or unsubstituted alkyl group, R1 represents hydrogen atom, hydroxy group, an alkoxy group, an alkoxycarbonyl group or a haloalkyl group] or its pharmaceutically acceptable salt.

    摘要翻译： 本发明提供具有免疫调节活性的8-氧代腺嘌呤化合物，例如干扰素诱导活性，可用作抗病毒剂和抗变应性剂，其由下式（1）表示：[其中环A表示6-10元 芳香族碳环等，R表示卤素原子，烷基等，n表示0-2的整数，Z1表示亚烷基，X2表示氧原子，硫原子，SO2，NR5，CO，CONR5，NR5CO 等等，Y1，Y2和Y3独立地表示单键或亚烷基，X1表示氧原子，硫原子，NR4（R4是氢原子或烷基）或单键，R2表示取代或未取代的烷基 基团，R 1表示氢原子，羟基，烷氧基，烷氧基羰基或卤代烷基]或其​​药学上可接受的盐。